Skip to main content
Saudi Pharmaceutical Journal : SPJ logoLink to Saudi Pharmaceutical Journal : SPJ
. 2016 Apr 30;25(2):149–164. doi: 10.1016/j.jsps.2016.04.025

The Pharmacological Potential of Rutin

Aditya Ganeshpurkar a,b,, Ajay K Saluja a,c
PMCID: PMC5355559  PMID: 28344465

Abstract

The contemporary scientific community has presently recognized flavonoids to be a unique class of therapeutic molecules due to their diverse therapeutic properties. Of these, rutin, also known as vitamin P or rutoside, has been explored for a number of pharmacological effects. Tea leaves, apples, and many more possess rutin as one of the active constituents. Today, rutin has been observed for its nutraceutical effect. The present review highlights current information and health-promoting effects of rutin. Along with this, safety pharmacology issues and SAR of the same have also been discussed.

Keywords: Anticancer, Antidiabetic, Antimicrobial, Organ protection, Rutin

1. Introduction

Medicinal plants are an integral part of traditional medicine since ancient era. Drug discovery process has witnessed phytochemicals for discovery of new leads (Grdina et al., 2002, Weiss and Landauer, 2003, Arora et al., 2005). Flavonoids, polyphenolic compounds, are one of the important classes of plant derived chemicals that contain benzopyrone moiety. About 4000 types of flavonoids have been reported to be present in plants (Guardia et al., 2001).

Rutin (3,3′,4′,5,7-pentahydroxyflavone-3-rhamnoglucoside, Fig. 1) is a flavonol, abundantly found in plants, such as passion flower, buckwheat, tea, and apple. It is a vital nutritional component of food stuff (Harborne, 1986). Rutin, also called as rutoside, quercetin-3-rutinoside, and sophorin is a citrus flavonoid glycoside found in buckwheat (Kreft et al., 1997). The name ‘rutin’ comes from the plant Ruta graveolens, which also contains rutin. Chemically it is a glycoside comprising of flavonolic aglycone quercetin along with disaccharide rutinose. It has demonstrated a number of pharmacological activities, including antioxidant, cytoprotective, vasoprotective, anticarcinogenic, neuroprotective and cardioprotective activities (Javed et al., 2012, Richetti et al., 2011, Nassiri-Asl et al., 2010, Mellou et al., 2006, Trumbeckaite et al., 2006, Schwedhelm et al., 2003, Janbaz et al., 2002, La Casa et al., 2000).

Figure 1.

Figure 1

Chemical structure of rutin.

The present review focuses on the pharmacological potentials as studied in various experimental models (see Table 1).

Table 1.

Anticancer effects of rutin on different cell lines.

Cell line Type Significant benefit achieved Reference
HL-60 Leukemia Significant reduction in tumor size Lin et al. (2012)
SW480 Colon cancer Less harmful effects on body weight and relative organ weight in mice, increased mean survival time Alonso-Castro et al. (2013)
LAN-5 Neuroblastoma Decreased BCL2 expression and BCL2/BAX ratio along with reduction in levels of MYCN mRNA level and the secretion of TNF-α Y.S. Chen et al. (2013)
CRC Colorectal Cell cycle arrest and/or apoptosis Araújo et al. (2011)
B16F10 Pulmonary metastasis Reduction in the number of metastatic nodules Martínez Conesa et al. (2005)
B16 melanoma Melanotic melanoma Augmentation of tumor mass, inhibition of melanin formation Drewa et al. (1998)
HTC hepatic cells Hepatic carcinoma Cytotoxic effect Cristina Marcarini et al. (2011)

2. Pharmacological actions

2.1. Central nervous system

2.1.1. Prevention of neuroinflammation

Rutin has demonstrated the neuroprotective effect on brain ischemia. Administration of rutin caused attenuation of ‘ischemic neural apoptosis’ due to the embarrassment of p53 expression and lipid peroxidation along with increment in ‘endogenous antioxidant defense enzymes’ (Khan et al., 2009). It has been found to be useful in hypoxic, glutamate and oxidative stress (Pu et al., 2007). Reduction of ‘neuroinflammation’ in rat model of ‘sporadic dementia of Alzheimer type’ (Javed et al., 2012) and neuroprotective effects in ‘dexamethasone-treated mice’ (Tongjaroenbuangam et al., 2011) were observed on rutin administration.

2.1.2. Promotion of neural crest cell survival

The neural crest is progenitor comprising of neural and mesenchymal potentials. Treatment of rutin to trunk neural crest cells increased their viability without altering cell differentiation and proliferation which could be due to modulation of ERK2 and PI3K pathways (Nones et al., 2012).

2.1.3. Sedative activity

CNS and behavioral activity of rutin were on hole board, thiopental-induced sleeping time and locomotor activity tests in mice. Rutin, given by intraperitoneal route caused a depressant action on the CNS. Research confirmed the CNS depressant activity of rutin was unlikely due to the involvement of GABAA receptor (Fernández et al., 2006).

2.1.4. Anticonvulsant activity

Rutin also possesses anticonvulsant activity and seems to be safe for patients with epilepsy as it does not alter the activity of any of the administered antiepileptic drugs nor demonstrates any adverse effects (Nieoczym et al., 2014).

2.1.5. Anti-Alzheimer activity and treatment of hyperkinetic movement disorder

Rutin suppressed activity of proinflammatory cytokines by diminishing TNF-α and IL-1β production in microglia. Such an effect seems to be useful in the treatment of Alzheimer’s disease as evident by prevention of β-amyloid oligomeric cytotoxicity (Wang et al., 2012). Rutin caused attenuation of streptozotocin-induced inflammation by decreasing the activity of the glial fibrillary acidic protein, interleukin-8, cyclooxygenase-2, inducible nitric oxide synthase and nuclear factor-kB and thereby prevented gross anatomical changes in rat hippocampus. Such an effect could be useful in averting cognitive deficits and proves to be beneficial in the treatment of ‘sporadic dementia of Alzheimer type’ (Javed et al., 2012).

‘Tardive dyskinesia’ is a motor disorder of the orofacial region raised due to chronic treatment with neuroleptic drugs, and is considered as a chief clinical concern in the treatment of schizophrenia. In a study, in haloperidol-induced orofacial dyskinesia, rutin treatment reversed behavioral changes such as orofacial dyskinetic movements, stereotypic rearing, locomotor activity, and percent retention along with restoration of biochemical and neurochemical parameters. Thus, rutin seems to be a lead molecule in the treatment of hyperkinetic movement disorder (Bishnoi et al., 2007).

2.1.6. Antidepressant effects

Forced swimming test and tail suspension test in mice were utilized to analyze ‘antidepressant-like effects’ of rutin isolated from Schinus molle. There was a reduction in the immobility time in the tail suspension test. There was no alteration in locomotor activity. Studies demonstrated the antidepressant-like effect of rutin mediated due to increasing the availability of serotonin and noradrenaline in the synaptic cleft (Machado et al., 2008).

2.1.7. Stroke

Stroke could be regarded as a decisive public health issue that seems to be an important cause of fatality and disability in adults globally (Lloyd-Jones et al., 2009). Oxidative stress and inflammation are two of the pathological events observed after ‘ischemic injury’ in the brain (Deb et al., 2010). Protective effect of rutin an animal model of focal cortical ischemia induced by unilateral thermocoagulation of superficial blood vessels of the motor (M1) and somatosensory (S1) primary cortices was studied. Rutin administration significantly promoted recovery of sensorimotor loss which was observed due to the reduction of neurodegeneration in the periphery of cortical injury (Ortolani et al., 1995).

2.2. Analgesic and antiarthritic activities

2.2.1. Analgesic and antinociceptive effects

Analgesic effect of rutin was studied by hot plate test on swiss albino mice whereby the analgesic effect of rutin was established (Rylski et al., 1979). Further, it was also confirmed that rutin exhibited peripheral and central antinociceptive activities (Selvaraj et al., 2014).

2.2.2. Antiarthritic effects

Animals treated with rutin were observed with significant decrement in rheumatoid arthritis and Fanconi anemia by inhibiting ‘oxygen radical overproduction’ (Ostrakhovitch and Afanas’ev, 2001). In adjuvant arthritis rat model, rutin inhibited acute and chronic phases of inflammation. Rutin was the most active in the chronic stage of inflammation (Guardia et al., 2001). Due to antifungal and anti-arthritic effects, rutin has a therapeutic effect on septic arthritis caused by Candida albicans (Han, 2009). Further in an independent study, rutin slowed down inflammatory and catabolic cartilage markers in osteoarthritic lesions in the Hartley guinea pig (Horcajada et al., 2014).

2.3. Endocrine system

2.3.1. Antidiabetic effects

Streptozotocin is a toxic chemical known to deplete levels of insulin by destroying pancreatic islets. Streptozotocin selectively assaults pancreatic β-cells by generating free radicals of oxygen and nitrogen monoxide along with reducing levels of NAD and NADP. Excessive production of glucose and its decreased utilization by tissues serve as the fundamental bases of hyperglycemia (Chattopadhyay, 1993). In a study, chronic administration of rutin in streptozotocin-induced diabetic rats caused a decrement in plasma glucose, augmentation in insulin levels, and restitution of glycogen content and glycolytic enzymes. Significant rejuvenation of pancreatic islets along with diminished fatty infiltrate was observed in rutin-treated diabetic rats (Stanley Mainzen Prince and Kamalakkannan, 2006, Srinivasan et al., 2005). Diminution of fasting plasma glucose, glycosylated hemoglobin, C-peptide, and malondialdehyde levels was observed in rutin treated streptozotocin diabetic rats (Kamalakkannan and Prince, 2006). Rutin averted the levels of enzymes viz. ALT, AST, and LDH in the serum, liver, and heart demonstrating a protective effect on hepatic (Fernandes et al., 2010) and cardiac toxicity (Krishna et al., 2005) associated due to streptozotocin. Alteration in the activity of matrix metalloproteinase and protection to kidney against streptozotocin-induced damage was observed (Kamalakkannan and Stanely Mainzen Prince, 2006). Rutin stimulated glucose uptake in the soleus muscle, and effect was thought to be mediated through extracellular calcium and calcium-calmodulin-dependent protein kinase II activation. Increase in intracellular calcium concentration is involved in DNA activation which was mediated by rutin (Kappel et al., 2013). Rutin added for glycemic control via enhancement of insulin receptor kinase activity, thus aided in promoting ‘insulin signaling pathway’ that caused increased GLUT4 translocation and augmented glucose uptake (Hsu et al., 2014).

2.3.2. Anti-hypercholesterolemic effects

Rutin is a ‘selective and non-toxic modulator’ of hypercholesterolemia. In a study conducted on diet-induced hypercholesterolemic Golden Syrian hamster model, rutin significantly reduced plasma triglyceride levels in experimental animals (Kanashiro et al., 2009). Along with this, rutin also caused a decrement in levels of total cholesterol and HDL cholesterol (da Silva et al., 2001).

In a high-cholesterol diet fed male wistar rats, rutin administration demonstrated protective effect against the hepatotoxicity as evident by decrement of the plasma level of alanine transaminase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), and low-density lipoprotein (LDL) (Al-Rejaie et al., 2013). In another study, it was established that chronic consumption of flavonoids such as rutin could be favorable to cardiovascular health (Kalgaonkar et al., 2010).

2.3.3. Thyroid uptake promotion

‘Thyroid iodide uptake’ mediated via sodium-iodide symporter plays a pivotal role in thyroid hormone biosynthesis and also plays a key role in diagnosis and treatment of various thyroid diseases. However, some of the patients with thyroid cancer are obstinate to radioiodine therapy, which reduced iodine uptake ability, that remarkably reduces the probability of endurance. Thus, it becomes necessary to search for natural agents that aid in the uptake of thyroid iodide.

In a study, rutin caused a minor reduction in levels of serum T4 and T3 without changing serum thyrotropin. There was a significant increase in hypothalamic, pituitary and brown adipose tissue type 2 deiodinase along with the diminution of liver type 1 deiodinase activities. Administration of rutin was observed with increment in thyroid iodide uptake that could be due to an elevation in the activity of sodium-iodide symporter. The study demonstrates the effectiveness of rutin as an adjuvant in radioiodine therapy (Gonçalves et al., 2013).

2.4. Cardiovascular system

2.4.1. Hypertension

Buckwheat, a rich source of rutin is found to prevent oxidative damage in ‘aortic endothelial cells’ by lowering nitrotyrosine immunoreactivity. Germinated extract of buckwheat demonstrated antihypertensive effect and possibly shelter ‘arterial endothelial cells’ by detrimental effects of oxidative stress (Kim et al., 2009). Reduction in oxidative stress due to rutin, when administered by oral route, is the key reason for the restoration of ‘impaired baroreflex sensitivity’ and ‘vascular reactivity’ in hypertensive rats (Mendes-Junior et al., 2013). By augmenting NO production in human endothelial cells, rutin improved endothelial functions (Ugusman et al., 2014).

2.4.2. Blood coagulation

Chan et al. (2009) attempted to study effects of the rutin on the anticoagulant activity of oral warfarin and the protein binding along with pharmacokinetics of its enantiomers in rats. Rutin enhanced the in vitro serum protein binding of S- and R-warfarin. Rutin treatment significantly decreased the elimination half-life of S-warfarin by 37% as a result of the 69% increase in unbound clearance of the S-enantiomer. In a nutshell, concomitant administration of rutin possibly reduces the anticoagulant effect of racemic warfarin (Chan et al., 2009).

2.4.3. Antiplatelet aggregatory effect

Rutin in vitro caused concentration-dependent inhibition of platelet activating factor induced washed rabbit platelet aggregation, and intra-platelet free calcium concentration elevation was induced by platelet activating factor which was inhibited by rutin in a dose-dependent manner (Chen et al., 2002).

2.5. Gastrointestinal system

2.5.1. Antiulcer effects

A peptic ulcer is infirmity that influences the substantial population in the world. Ulcers are observed when disparity occurs among ‘aggressive’ and ‘protective’ factors at the luminal surface of the gastric epithelium. HCl, pepsins, nonsteroidal anti-inflammatory drugs, Helicobacter pylori, bile acids, ischemia, hypoxia, smoking, alcohol, etc. include dynamic features whereas defensive factors comprise of bicarbonate, a mucus layer, mucosal blood flow, PGs and growth factors (Kalant et al., 2007).

Ethanol is ill-reputed agent known to produce damage to gastric mucosa in animal and clinical studies. Ethanol in a concentration higher than 400 ml/l causes significance in gross morphology of stomach which is observed by mucosal hyperemia, necrosis, edema and mucosal or submucosal hemorrhage (Oates and Hakkinen, 1988, Szabo and Goldberg, 1990). Oxygen-derived free radicals could be regarded as a key reason for the formation of lesions (Pihan et al., 1987, Szelenyi and Brune, 1988). Rutin pretreatment before administration of ethanol afforded significant protection against necrosis. Restoration in the levels of glutathione peroxidase along with ‘anti-lipoperoxidant effect’ was observed (La Casa et al., 2000). Similarly in an indomethacin-induced model of ulcers, rats pretreated with rutin caused reestablishment of altered oxidative stress and biochemical parameters possibly due to neutrophil infiltration, suppression of oxidative stress generation and replenishing nitrite/nitrate levels. Protective effects are also evident by histopathological investigations (Abdel-Raheem, 2010).

Another investigation provides insight into the molecular mechanism of action of rutin over gastric proton pumps. Rutin demonstrated concentration-dependent inhibition of goat gastric ATPase, with IC50 = 36 μg/ml, making it that rutin exerts an antiulcer effect by inhibiting the gastric proton pump (Dubey et al., 2013, Dubey et al., 2013).

2.6. Respiratory system

2.6.1. Antiasthmatic activity and other associated effects

The antiasthmatic activity of rutin was studied in ovalbumin-sensitized conscious guinea pigs challenged with aerosolized ovalbumin where airway resistance during the immediate phase response and late-phase response was determined. Rutin significantly inhibited specific airway resistance and immediate-phase response along with reticence of histamine, phospholipase A2, and eosinophil peroxidase. There was reduced conscription of neutrophils and eosinophils into the lung (Jung et al., 2007). Use of rutin was also suggested in whooping cough along with vitamins C and K (De Sarmento and Kimura, 1957). In cats and whippets, rutin has been effectively used in the management of idiopathic chylothorax (Kopko, 2005, Gould, 2004, Schuller et al., 2011).

2.7. Bones

2.7.1. Antiosteoporotic and antiosteopenic effect

Osteoporosis is a skeletal disorder observed by a decrement in bone strength, that is associated with augmented risk of fracture (Bhutani and Gupta, 2013). This condition is affecting elderly citizens globally and seems to be budding health predicament. Osteoporosis is observed in the case when bone resorption by osteoclasts surpasses bone formation by osteoblasts (Lau and Guo, 2011, Roux, 2010). All therapeutic strategies for treatment of osteoporosis emphasize inhibition of ‘osteoclast-mediated bone resorption’. Parathyroid hormones are only classes of agents that ‘stimulate bone formation’ (Hodsman et al., 2005). In osteogenic-related assays, rutin caused proliferation and differentiation of human osteoblast-like MG-63 cells. There was also increase in the activity of alkaline phosphatase, expression of collagen type I and degree of mineralization (Hyun et al., 2014). Similar effects have been observed with rat calvarial osteoblast cells (Yang et al., 2006). Rutin inhibits osteoclast formation by decreasing oxygen reactive species and TNF-alpha by inhibiting activation of NF-kappaB (Kyung et al., 2008). Rutin inhibits ovariectomy-induced osteopenia in rats by slowing down resorption and increasing osteoblastic activity (Horcajada-Molteni et al., 2000). Thus, rutin can also be regarded as ‘osteoblast stimulant’.

2.8. Eye

2.8.1. Anticataract and ophthalmic effect

Formation of advanced glycation end products (AGE) is associated with cataract, a diabetic complication. Thus, inhibition of such glycation could be a useful strategy to prevent such complication. In this study, rutin caused embarrassment of glycation of proteins, chelation of metal complexes and partly inhibiting post-Amadori formation (Muthenna et al., 2010). In another study in wistar rat pups, selenium was used to induce cataract and protective effect of rutin in retarding cataractogenesis was investigated. Eye lens of rats treated with rutin were observed with restoration of lenticular antioxidant enzymes along with decrement in malondialdehyde formation. Experimental outcomes suggest that rutin prevented cataractogenesis possibly due to antioxidant mechanism (Isai et al., 2009).

Oral administration of rutin has been observed with an improved reduction in intraocular pressure (Vetrugno et al., 2012). Involvement of vitamins B1, B2, forskolin, and rutin demonstrates ‘defending effect’ on the ocular surface which aids to re-establish a ‘normal equilibrium’ of the tear film altered due to toxins (Nebbioso et al., 2013).

2.9. Excretory system

2.9.1. Diuretic effect

Quercetin, a metabolite of rutin, which is abundantly found in Hibiscus sabdariffa Linn acted on vascular endothelium causing nitric oxide release, leading to increasing renal vasorelaxation by increasing kidney filtration (Alarcón-Alonso et al., 2012).

2.10. Reproductive system

2.10.1. Effect on sperm quality and male reproductive organs

Rutin, in a study, afforded protective effect on damage to human sperm induced by lipid peroxidation (Moretti et al., 2012). Rutin also demonstrated possible protection to testicular tissue and reproduction from oxidative stress observed in type 1 diabetes mellitus (Butchi Akondi et al., 2011) along with amelioration of cyclophosphamide-induced reproductive toxicity (Abarikwu et al., 2012) and testicular ischemia–reperfusion-induced oxidative stress in rats (Akondi et al., 2011).

2.11. Anticancer effects

Cancer includes a group of diseases that are characterized by the abnormal growth of cells that latently assault or spread to other parts of the body (Markert and Markert, 1968). Flavonoids are known to demonstrate an extensive assortment of biological effects, comprising of ‘antioxidant and radical-scavenging activities’. Reactive oxygen species have been associated with the pathogenesis of several diseases such as atherosclerosis and certain cancers.

Rutin has been extensively studied for anticancer/antineoplastic effects. In a study, human leukemia HL-60 cells were implanted in a murine model, and rutin (dose 120 mg/kg) caused a significant reduction in tumor size justifying antileukemic potential (Lin et al., 2012). In an independent study, rutin when administered to SW480 tumor cell lines (human colon cancer cell lines), was observed with less detrimental effects on the body and relative organ weight in mice along with an increment of mean survival time of 50 days (Alonso-Castro et al., 2013). Chem et al., demonstrated anti-neuroblastoma effect of rutin, where, rutin significantly inhibited the growth of LAN-5 cells and chemotactic ability. The study demonstrated that rutin could decrease BCL2 expression and BCL2/BAX ratio along with a reduction in levels of MYCN mRNA level and the secretion of TNF-α (C.Y. Chen et al., 2013). Rutin is also known to inhibit cancer cell growth by cell cycle arrest and/or apoptosis, along with inhibition of proliferation, angiogenesis, and/or metastasis in colorectal cell lines (Araújo et al., 2011). Rutin analog, quercetin, is studied against the proliferation of the ovarian cancer cell line OVCA 433, where dose-related inhibition was observed (Scambia et al., 1990). In another study, quercetin augmented apoptosis and barred metastasis in a model of pancreatic cancer (Mouria et al., 2002). Rutin also seems to be useful as an adjuvant in radioiodine therapy (Gonçalves et al., 2013).

2.12. Chemotherapeutic activity

2.12.1. Antibacterial activity

Rutin is extensively studied for antimicrobial activity against various strains of bacteria. It has demonstrated a profound degree of inhibition on growth of bacteria Escherichia coli (Araruna et al., 2012). Rutin, quantified in honey has shown inhibitory effects over Proteus vulgaris, Shigella sonnei and Klebsiella sp. (Pimentel et al., 2013). Antimicrobial activity against Pseudomonas auruginosssa and Bacillus subtilis has also been documented (Dubey et al., 2013, Dubey et al., 2013). In situ antimicrobial activity of rutin and other polyphenols in the food system has been studied, and the results demonstrate a promising involvement of flavonoids in the preservation of food (Stojković et al., 2013).

Bernard et al., demonstrated that rutin by inhibiting DNA isomerase IV demonstrated antibacterial activity against E. coli (Bernard et al., 1997). In a study, rutin synergistically enhanced antibacterial activity of other flavonoids against Bacillus cereus and Salmonella enteritidis. Minimum inhibitory concentration value for kaempferol was remarkably decreased by the addition of rutin (Arima et al., 2002).

2.12.2. Antifungal activities

Rutin demonstrated antifungal activity against the strain of Candida gattii with a minimum inhibitory concentration of 60 μg/ml (Johann et al., 2011). It was suggested that chemical modification in rutin by the introduction of substitute group may alter physicochemical properties such as electron density, hydrophobicity and steric strain that may prove to be fruitful regarding increment of antifungal activity. Use of rutin in treatment of septic arthritis caused by C. albicans has also been suggested (Han, 2009).

2.12.3. Antimycobacterial activity

In a study, flavonoids rich extract containing rutin demonstrated antimycobacterial activity against Mycobacterium smegmatis (da Cruz et al., 2012).

2.12.4. Larvicidal activity

In a study, rutin significantly inhibited growth and propagation of larvae of S. aegypti where maximum mortality of larvae was observed at 72 h (Dubey et al., 2013, Dubey et al., 2013).

2.12.5. Antimalarial activity

Antimalarial effect of rutin in association with chloroquine was observed on white leghorn chickens infected with Plasmodium (Bennettinia) juxtanucleare (Silveira et al., 2009). In another study, biochemical mechanism of the antimalarial activity of Azadirachta indica leaf extract revealed the presence of an abundant amount of quercetin, an active metabolite of rutin (Iwu et al., 1986). Recently, the antiplasmodial activity of quercetin is documented against Plasmodium falciparum (Ganesh et al., 2012).

2.12.6. Antiretroviral activity

In a study, sodium rutin sulfate, a sulfated rutin analog, was investigated for anti-HIV activity against HIV-1 X 4 viruses IIIB, HIV-1 R5 isolates Ada-M and Ba-L strains. The mechanism by which sodium rutin sulfate demonstrated antiretroviral effect was a blockade of viral entry and virus-cell fusion which was mediated via interaction with HIV-1 envelope glycoprotein (Tao et al., 2007).

2.12.7. Antiviral activity

Antiviral agents for the treatment of infections caused by retroviruses, orthomyxoviruses, herpes viruses, hepatitis B virus and hepatitis C virus are widely available (De Clercq and Field, 2006). Owing to the high incidence of viral infections along with no precise treatment for ‘appearance of new resistant viral strains’, its seems to be necessary to develop novel antiviral drugs.

Rutin has been tested against vesicular stomatitis virus on mouse fibroblasts and protected cells for about 24 h (Wacker and Eilmes, 1978). In the case of canine distemper virus infection, rutin affords immense viral embarrassment when added at the times of adsorption and penetration in the viral replicative cycle (Carvalho et al., 2013). Rutin a chief constituent of Capparis sinaica Veill demonstrated profound antiviral effect against avian influenza strain H5N1 using plaque inhibition assay in the Madin-Darby canine kidney (Ibrahim et al., 2013).

2.13. Hair

Apoptosis of hair follicular cells is a leading cause of hair follicle degeneration. In a study, apoptosis of human follicular dermal papilla cells was observed after treatment with staurosporine; this event was completely introverted by exposure to rutin, spermidine, and zeaxanthin. There was the preservation of expression of anti-apoptotic molecules such as Bcl-2, MAP-kinases and their phosphorylated forms, which concludes the use of rutin in the prevention of apoptosis of hair follicular cells, one of the leading causes of baldness (Carelli et al., 2012).

2.14. Skin

2.14.1. Sunscreen effects

The desire for having healthy, beautiful and disease free skin is being observed from the eternal era. History of cosmetics and skin care product dates back in ancient Greek, Roman and Egyptian civilization. Advances in sciences and technology along with the development of modern chemistry have made this dream easy (Draelos, 2000). Exposure to ultraviolet B radiations produces ‘oxidative and inflammatory skin damage’ and augments jeopardy of skin ‘carcinogenesis. Rutin has been studied to explore the effects of rutin on UVB-induced inflammation in mouse skin in vivo. Topical application of rutin on mice skin 30 min before UVB irradiation reduced epidermal hyperplasia and the levels of proteins. There was also significant inhibition of UVB-induced expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) which could be due to inhibition of p38 MAP kinase and JNK that caused diminution UVB-induced expression of COX-2 in mouse skin (Choi et al., 2014). In a study conducted by Choquenet et al. (2008), rutin when incorporated in oil-in-water emulsions (concentration 10% w/w), sun protection factor (SPF) values comparable to ‘homosalate’ were observed. Along with TiO2, SPF values approached to 30.

2.14.2. In atopic dermatitis

In an atopic dermatitis model in BALB/c mice by repeated local exposure of house dust mite (Dermatophagoides farinae) extract (DFE) and 2,4-dinitrochlorobenzene (DNCB) to the ears, rutin treatment caused suppression of interleukin (IL)-4, IL-5, IL-13, IL-31, IL-32 and interferon (INF)-γ in the tissue. In 2,4-dinitroflourobenzene-sensitized a local lymph node assay for allergic contact dermatitis, rutin caused suppression of allergic contact dermatitis based on ear thickness and lymphocyte proliferation, serum IgG2a levels, and expression of INF-γ, IL-4, IL-5, IL-10, IL-17 and tumor necrosis factor-α in allergic contact dermatitis ears. This study signifies anti-atopic dermatitis and allergic contact dermatitis activity of rutin (Choi and Kim, 2013). Rutin has also demonstrated anti aging effects on the skin (Odetti et al., 1990). Thus, rutin could be regarded as most effective topically applied compound given its antioxidant activity and skin penetration profile (Alonso et al., 2014).

2.15. Immune effects

Vibrio alginolyticus challenge was studied based on immune and physiological response to rutin in white shrimp. In this study, physiological, innate non-specific immune responses, respiratory bursts and superoxide dismutase activity against the pathogen were analyzed. Rutin from Toona sinensis was administered to shrimp. In brief, shrimps treated with rutin maintained lower glucose, lactate, and lipid levels in response against the pathogen. Survival rates of shrimps treated with rutin were more (Hsieh et al., 2008). Another study demonstrates promotion of the activity of macrophage phagocytosis in cells (Lin et al., 2009).

2.16. Body strength

2.16.1. Anti fatigue activity

Fatigue is an indication which is associated with person’s health. Fatigue is related to deterioration in ‘physical performance’. Extreme exercise is associated with accretion of surplus reactive free radicals that leads to an oxidative stress injury to the body. Depletion of energy along with the accumulation of excess metabolite is the key reasons for fatigue (Yu et al., 2010, Fitts, 1994, Coombes et al., 2002, You et al., 2011). Rutin administration in mice prevented depletion of superoxide dismutase and reduced glutathione. After seven days of treatment with rutin, mice were sacrificed and analyzed for soleus muscle and brain for peroxisome proliferator-activated receptor-α coactivator and sirtuin one mRNA expression. Up-regulation of the CB1 cannabinoid receptor-interacting protein 1, myelin basic protein, Rho GDP dissociation inhibitor (GDI) alpha, and TPI indicated that rutin treatment inhibited condition anxiety via up-regulation of the expression of anxiety-associated proteins (Su et al., 2014) and hence in nutshell it can be regarded as treatment with rutin improves the various mutilations allied with physical fatigue.

2.17. Organ protective effects

2.17.1. Neuroprotective activity

In mice model, rutin inhibited oxaliplatin-induced chronic painful peripheral neuropathy. Oxaliplatin is one of the most important platinum compounds used in colorectal cancer chemotherapy. However, it suffers from a drawback of peripheral which seems to be difficult to treat. Rutin significantly decreased oxaliplatin-induced peroxidative changes in the spinal cord and lipid peroxidation along with inducible nitric oxide (Azevedo et al., 2013).

2.17.2. Retinoprotective activity

Effect of rutin on ocular blood flow by ‘colored microsphere technique’ was determined. Electroretinography was used to determine the b-wave recovery which is a tool for estimation of retinal function recovery. Rutin increased ocular blood flow and demonstrated a remarkable effect on retinal function recovery (Chiou and Xu, 2004).

2.17.3. Protective effect on lung tissue

Acute lung injury is severe disease observed with ‘high mortality and morbidity.’ Till date, there is no therapeutic stratagem established. Rutin demonstrated protective effects on histopathological changes in lung tissue along with prevention of ‘infiltration of polymorphonuclear granulocytes in bronchoalveolar lavage fluid’. There was also a reduction in secretion of lipid peroxidation and proinflammatory cytokines. The activity of antioxidant enzymes such as catalase, glutathione peroxidase, superoxide dismutase, and heme oxygenase-1 caused by lipopolysaccharide was reversed by rutin (Yeh et al., 2014). Pretreatment of rutin caused inhibition of lipopolysaccharide-induced arterial blood gas exchange and neutrophils infiltration in the lungs. There was suppression of macrophage inflammatory protein-2 and matrix metalloproteinase-9 (Chen et al., 2014). Another study demonstrated that rutin effectively inhibited vascular cell adhesion molecule-1 and inducible nitric oxide synthase (Huang et al., 2014). There is also evidence that rutin prevented early adult respiratory distress syndrome possibly due to inhibition of lipid peroxidation (Ortolani et al., 2000).

2.17.4. Cardioprotective effects

Ischemic heart disease is one of the primary reasons for ‘morbidity and mortality’ all along the globe. The pathophysiology underlying damage at a cellular level raised due to ischemia is multifaceted. ‘Reactive oxygen species’ are identified to participate and play a key task in the pathogenesis of several diseases (Li and Jackson, 2002). It is well known that ischemic tissues produce ‘oxygen-derived free radicals’ that are known to cause oxidative damage to membrane lipids, proteins, and carbohydrates that predispose to ‘qualitative and quantitative alterations’ of the myocardium (Burton et al., 1984). Rutin was studied for cardioprotective effect by ischemia–reperfusion-induced myocardial infarction in normal and streptozotocin diabetic rats. Rutin administration significantly offered cardioprotection and restricted infracts size in normal and diabetic rats (Annapurna et al., 2009, Krishna et al., 2005). The mechanism lying behind this protection could be attenuation of lipid peroxidation in myocardial tissues (Ali et al., 2009).

Isoproterenol is β-adrenergic agonist used to treat bradycardia and heart block (Shen, 2008). However, frequent administration of it may lead to cardiac toxicity observed by an increase in the activity of serum cardiac marker enzymes viz lactate dehydrogenase, aspartate transaminase, creatine kinase, and alanine transaminase along with significant decrease in the activity of these enzymes in the heart. Rutin restored the levels of cardiac marker enzymes along with a reduction in lipid peroxidation. The study suggests the cardioprotective effect is due to the virtue of the antioxidant effect of rutin (Chan et al., 2009).

Repression of isoproterenol-induced increase in angiotensin II and aldosterone in plasma was observed after administered by rutin. Along with this, overexpression of transforming growth factor β1, connective tissue growth factor, and excessive deposition of extracellular matrix in isoproterenol-treated myocardial tissues was observed in the group of animals treated with rutin (Li et al., 2013).

2.17.5. Prevention of splenocyte apoptosis

Rutin is known to alter the viability and function of mitogen-stimulated splenocytes and thymocytes compared with non-stimulated cells. In a study, when splenocytes were cultured with mitogens, it was observed that there was a decrease in interferon-gamma production along with decrement in splenocyte apoptosis (Roseghini et al., 2007).

2.17.6. Hepatoprotective activity

Cirrhosis is the destruction of hepatocytes and following substitution with ‘scar tissue’ which alter the flow of blood through liver leading to the death of hepatocytes and n function of the liver (Wang and Nagrath, 2010). The event of liver damage is followed by ‘hepatic fibrosis’ whereby regeneration of apoptotic cells is observed after ‘repeated injury’ (Friedman et al., 2002). In the event, when the death of regenerating cells occurs, deposition of extracellular matrix is observed, which leads to deposition of ‘fibrillar collagen’ (O’Connell and Rushworth, 2008). Such pathology is difficult to treat. The effectiveness of treatment with colchicines, interferons, penicillamine and corticosteroids are contradictory and seem to be questionable. As oxidative stress is one of the causes beneath cirrhosis, use of antioxidants could be a unique strategy for treatment. Rutin is extensively studied for hepatoprotective activity in experimental animals. Khan et al., 2012a, Khan et al., 2012b evaluated the protective effect of rutin in carbon tetrachloride (CCl₄)-induced liver injuries in rats. Administration of rutin caused a decrement in levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transpeptidase in serum raised due to carbon tetrachloride. The level of cholesterol in blood was regulated whereas the level of endogenous liver antioxidant enzymes such as catalase, superoxide dismutase, glutathione peroxidase, glutathione-S-transferase, glutathione reductase and glutathione was increased, whereas lipid peroxidation was decreased in a dose-dependent manner. Along with this, the activity of p53 and CYP2E1 was restored by treatment with rutin. In an independent study in BALB/c mice, rutin treatment allayed oxaliplatin-induced hepatotoxicity and neurotoxicity. Prevention of mechanical allodynia along with histopathological observations suggested the protective role of rutin in the prevention of hepatotoxicity (Schwingel et al., 2014).

2.17.7. Nephroprotective activity

Nephropathy is one of the most encountered pathogenesis observed in the populace all over the world regardless of age, caste, creed, race and environment. The reasons behind this condition result from anomalies rose due to different metabolic and physiological disturbances. Nephropathy is among the ten primary causes of death all along the globe (Zhang and Lindup, 1993). Gentamicin (Sonkar et al., 2014), ecstasy (Karami et al., 2014), cisplatin (Corcostegui et al., 1998), and carbon tetrachloride (Ogeturk et al., 2005) are some of the compounds known to demonstrate nephrotoxicity.

In a study, rutin demonstrated protective activity against oxonate-induced hyperuricemia and renal dysfunction in mice. Administration of rutin resulted in a the decrement in levels of serum urate, creatinine and blood urea nitrogen, serum and kidney uromodulin levels, and increased urine uromodulin, urate and creatinine excretion in hyperuricemic mice. There was a significant downregulation of mRNA and protein levels of mouse glucose transporter 9 and urate transporter 1, along with upregulation of mRNA and protein levels of organic anion transporter 1 and organic cation/carnitine transporters in the kidney of hyperuricemic mice. In a fructose-fed rat model for hyperuricemia, rutin blocked the NOD-like receptor three inflammasome activation and aided in the improvement in the signaling and reduced lipid accumulation in the kidney of rats (Hu et al., 2012) along with reversal of dysregulation of renal transporters (Hu et al., 2009). Inhibition of inducible nitric oxide synthase activity and reduction in 3-nitrotyrosine formation (Korkmaz and Kolankaya, 2013) along with inhibition of reactive oxygen species (Korkmaz and Kolankaya, 2010) in the kidneys seem to be an important approach to prevent renal ischemia/reperfusion injury.

In cisplatin-treated wistar rats, rutin pretreatment caused restoration of kidney function and oxidative stress biomarkers (Kamel et al., 2014). It partially inhibited effect on NFκB and TNF-α pathway mediated inflammation, caspase-3 mediated-tubular cell apoptosis, along with re-establishment of histopathological changes due to cisplatin administration (Arjumand et al., 2011). Rutin also demonstrated protective effects against potassium bromate-induced nephrotoxicity in rats. The decrement in DNA fragmentation, upregulation in the activity of antioxidant enzymes viz. catalase, superoxide dismutase, glutathione peroxidase, glutathione-S-transferase, glutathione reductase, and reduced glutathione along with a reduction in lipid peroxidation were observed (Khan et al., 2012a, Khan et al., 2012b).

2.17.8. Protective effect on blood vasculature

Rutin was found to resist damages in vascular beds due to a disturbance in myocardium supply leading to initial damage, however in a chronic model of ‘stenocardia in dogs,’ therapeutic effect of rutin is up to a limited extent (Pozin et al., 1996).

2.18. Protective effects on wounds

2.18.1. Wound healing activity

Rutin, formulated as hydrogel, when applied to skin lesions of rats, caused a decrease in wound area as compared to control hydrogels. There was a reduction in oxidative stress in wound area as signified by a reduction in lipid peroxidation and protein carbonyl content along with increased catalase activity (Almeida et al., 2012). Rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing have been formulated. These hydrogels promoted defined formation of neo-epithelium and thicker granulation, which is closer to the original epithelial tissue (Tran et al., 2011).

2.19. Radio modulatory effects

Radiation therapy is one of the principal strategies in anticancer therapy for treatment of various cancers; however, due to ill effects on normal tissues, its use is restricted. Ionizing radiations predispose to the generation of free radicals that damages DNA; cell death follows this event. Thus along with cancerous cells, the damage is observed with normal cells also. Some ‘radioprotectors’ have been screened; still, their clinical effectiveness is restricted due to toxicity with the frequent administration. In a study, rutin has been investigated for potential radioprotective effects. Rutin was administered to Swiss albino mice to assess its impact on ‘radiation-induced sickness along with the survival analyses’. Rutin at the dose of 10 mg/kg optimally demonstrated radioprotective effects. There was an increment in radiation tolerance and levels of antioxidant enzymes were restored along with a decrease in lipid peroxidation in liver (Patil et al., 2012). Similar protection by rutin against gamma radiations was also observed (Patil et al., 2013).

2.20. Pharmacokinetics

Absorption Intestine Andlauer et al., 2001, Carbonaro and Grant, 2005
Distribution 35 ± 2 μmol/1(as quercetin)
1.35 ± 0.37 microg/mL
Chen et al. (2010)
Metabolism Metabolites are 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxytoluene, m-hydroxyphenylacetic acid, 3-methoxy-4-hydroxyphenylacetic acid/homovanillic acid, and 3,5,7,3′,5′-pentahydroxyflavonol/quercetin Pashikanti et al. (2010)
Excretion About 10% in urine, rest unchanged in foeces Choudhury et al., 1999, Griffiths and Barrow, 1972

2.21. Drug interaction

Absorption of paclitaxel is increased when concurrently administered with rutin (Kumar et al., 2015). Rutin treatment cause increased the body’s resistance to drugs due to induction of the drug metabolizing enzymes in the liver; such an action has about the same magnitude with that of phenobarbital and pregnenolone-16 alpha-carbonitrile (Kourounakis and Rekka, 1986).

2.22. Safety pharmacology

Rutin has been studied for carcinogenicity and results have demonstrated practically and significantly no carcinogenic potential in non-inbred golden hamsters (Morino et al., 1982).

2.23. Structure–activity relationship

  • 4-Oxo group and the 2,3 double bond in the C ring in rutin may be related by its neuroprotective action (Khan et al., 2009).

  • The presence of sugar moiety (O-rha-glu) has no significant effect on the ileum, which indicates that presence of sugar substitution diminishes the biological activity of the flavonoids (Hammad and Abdalla, 1997).

  • Hydroxyl group in 5-position as well as the double bond and the double-bonded oxygen in the oxane ring is all necessary for the overall ability of flavonoids to inhibit phospholipase A2 activity, and that the hydroxyl groups in 3’- and 4’-position are required for selective inhibition of phospholipase A2-II (Lindahl and Tagesson, 1997).

  • Polyhydroxylated substitutions on rings A and B, a 2,3-double bond, a free 3-hydroxyl substitution and a 4-keto moiety, confer antiperoxidative properties to rutin (Ratty and Das, 1988).

  • Catechol group in the B-ring, a double bond between C2 and C3 at the C-ring, and ketone group in C4 at the C-ring are necessary for inhibitory effect on angiotensin-converting enzyme activity (Guerrero et al., 2012).

  • Rutin, whose C-3 position is glycosylated has a less free radical neutralizing activity that is aglycone quercetin (H.C. Chen et al., 2013).

  • The glycosylation decreases the AChE inhibitory activities of flavonoids and lowers the affinities for AChE by 1–5 times depending on the conjunction site and the type of sugar moiety (Xie et al., 2014).

  • The presence of a phenolic group in rutin is known to add hydrogen donation for scavenging the radiation-induced radicals, and to inhibit radiation-induced oxidative stress (Patil et al., 2013).

  • The presence of a glycosylation group in rutin greatly reduces vascular relaxation effect in porcine coronary artery (Xu et al., 2007).

3. Conclusion

As evident from aforesaid facts, rutin is phytochemical with multiple pharmacological activities. An ancient saying ‘an apple a day, keeps doctor away’ seems to be true as rutin, one of the important constituents of apples, has a wide array of biological activities. Hence, rutin can be regarded as a ‘vital phytochemical’ which is needed to be studied extensively to establish effective safety profile in human to get therapeutic benefits.

Footnotes

Peer review under responsibility of King Saud University.

References

  1. Abarikwu S.O., Otuechere C.A., Ekor M., Monwuba K., Osobu D. Rutin ameliorates cyclophosphamide-induced reproductive toxicity in male rats. Toxicol. Int. 2012;19(2):207–214. doi: 10.4103/0971-6580.97224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abdel-Raheem I.T. Gastroprotective effect of rutin against indomethacin-induced ulcers in rats. Basic Clin. Pharmacol. Toxicol. 2010;107(3):742–750. doi: 10.1111/j.1742-7843.2010.00568.x. [DOI] [PubMed] [Google Scholar]
  3. Akondi B.R., Challa S.R., Akula A. Protective effects of rutin and naringin in testicular ischemia-reperfusion induced oxidative stress in rats. J. Reprod. Infertility. 2011;12(3):209–214. [PMC free article] [PubMed] [Google Scholar]
  4. Alarcón-Alonso J., Zamilpa A., Aguilar F.A., Herrera-Ruiz M., Tortoriello J., Jimenez-Ferrer E. Pharmacological characterization of the diuretic effect of Hibiscus sabdariffa Linn (Malvaceae) extract. J. Ethnopharmacol. 2012;139(3):751–756. doi: 10.1016/j.jep.2011.12.005. [DOI] [PubMed] [Google Scholar]
  5. Ali M.S., Mudagal M.P., Goli D. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats. Pharmazie. 2009;64(2):132–136. [PubMed] [Google Scholar]
  6. Almeida J.S., Benvegnú D.M., Boufleur N., Reckziegel P., Barcelos R.C., Coradini K., de Carvalho L.M., Bürger M.E., Beck R.C. Hydrogels containing rutin intended for cutaneous administration: efficacy in wound healing in rats. Drug Dev. Ind. Pharm. 2012;38(7):792–799. doi: 10.3109/03639045.2011.628676. [DOI] [PubMed] [Google Scholar]
  7. Alonso C., Rubio L., Touriño S., Martí M., Barba C., Fernández-Campos F., Coderch L., Luís Parra J. Antioxidative effects and percutaneous absorption of five polyphenols. Free Radic. Biol. Med. 2014;75:149–155. doi: 10.1016/j.freeradbiomed.2014.07.014. [DOI] [PubMed] [Google Scholar]
  8. Alonso-Castro A.J., Domínguez F., García-Carrancá A. Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Arch. Med. Res. 2013;44(5):346–351. doi: 10.1016/j.arcmed.2013.06.002. [DOI] [PubMed] [Google Scholar]
  9. Al-Rejaie S.S., Aleisa A.M., Sayed-Ahmed M.M., Al-Shabanah O.A., Abuohashish H.M., Ahmed M.M., Al-Hosaini K.A., Hafez M.M. Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Wistar rat. BMC Complement. Altern. Med. 2013;13:136. doi: 10.1186/1472-6882-13-136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Andlauer W., Stumpf C., Fürst P. Intestinal absorption of rutin in free and conjugated forms. Biochem. Pharmacol. 2001;62(3):369–374. doi: 10.1016/s0006-2952(01)00638-4. [DOI] [PubMed] [Google Scholar]
  11. Annapurna A., Reddy C.S., Akondi R.B., Rao S.R. Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J. Pharm. Pharmacol. 2009;61(10):1365–1374. doi: 10.1211/jpp/61.10.0014. [DOI] [PubMed] [Google Scholar]
  12. Araruna M.K., Brito S.A., Morais-Braga M.F., Santos K.K., Souza T.M., Leite T.R., Costa J.G., Coutinho H.D. Evaluation of antibiotic & antibiotic modifying activity of pilocarpine & rutin. Indian J. Med. Res. 2012;135:252–254. [PMC free article] [PubMed] [Google Scholar]
  13. Araújo J.R., Gonçalves P., Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr. Res. 2011;31(2):77–87. doi: 10.1016/j.nutres.2011.01.006. [DOI] [PubMed] [Google Scholar]
  14. Arima H., Ashida H., Danno G. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci. Biotechnol. Biochem. 2002;66(5):1009–1014. doi: 10.1271/bbb.66.1009. [DOI] [PubMed] [Google Scholar]
  15. Arjumand W., Seth A., Sultana S. Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats. Food Chem. Toxicol. 2011;49(9):2013–2021. doi: 10.1016/j.fct.2011.05.012. [DOI] [PubMed] [Google Scholar]
  16. Arora R., Gupta D., Chawla R., Sagar R., Sharma A., Kumar R. Radioprotection by plant products: present status and future prospects. Phytother. Res. 2005;19:1–22. doi: 10.1002/ptr.1605. [DOI] [PubMed] [Google Scholar]
  17. Azevedo M.I., Pereira A.F., Nogueira R.B., Rolim F.E., Brito G.A., Wong D.V., Lima-Júnior R.C., de Albuquerque Ribeiro R., Vale M.L. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol. Pain. 2013;9:53. doi: 10.1186/1744-8069-9-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bernard F.X., Sable S., Cameron B., Provost J., Desnottes J.F., Crouzet J.F., Blanche F. Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob. Agents Chemother. 1997;41:992–998. doi: 10.1128/aac.41.5.992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bhutani G., Gupta M.C. Emerging therapies for the treatment of osteoporosis. J. Midlife Health. 2013;4:147–152. doi: 10.4103/0976-7800.118991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Bishnoi M., Chopra K., Kulkarni S.K. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. Fundam. Clin. Pharmacol. 2007;21(5):521–529. doi: 10.1111/j.1472-8206.2007.00512.x. [DOI] [PubMed] [Google Scholar]
  21. Burton K.P., McCord J.M., Ghai G. Myocardial alteration due to free radical generation. Am. J. Physiol. 1984;84:H776–H783. doi: 10.1152/ajpheart.1984.246.6.H776. [DOI] [PubMed] [Google Scholar]
  22. Butchi Akondi R., Kumar P., Annapurna A., Pujari M. Protective effect of rutin and naringin on sperm quality in streptozotocin (STZ) induced type 1 diabetic rats. Iran J. Pharm. Res. 2011;10(3):585–596. [PMC free article] [PubMed] [Google Scholar]
  23. Carbonaro M., Grant G. Absorption of quercetin and rutin in rat small intestine. Ann. Nutr. Metab. 2005;49(3):178–182. doi: 10.1159/000086882. [DOI] [PubMed] [Google Scholar]
  24. Carelli S., Hebda D.M., Traversa M.V., Messaggio F., Giuliani G., Marzani B., Benedusi A., Di Giulio A.M., Gorio A. A specific combination of zeaxanthin, spermidine and rutin prevents apoptosis in human dermal papilla cells. Exp. Dermatol. 2012;21(12):953–955. doi: 10.1111/exd.12029. [DOI] [PubMed] [Google Scholar]
  25. Carvalho O.V., Botelho C.V., Ferreira C.G., Ferreira H.C., Santos M.R., Diaz M.A., Oliveira T.T., Soares-Martins J.A., Almeida M.R., Silva A., Jr. In vitro inhibition of canine distemper virus by flavonoids and phenolic acids: implications of structural differences for antiviral design. Res. Vet. Sci. 2013;95(2):717–724. doi: 10.1016/j.rvsc.2013.04.013. [DOI] [PubMed] [Google Scholar]
  26. Chan E., Hegde A., Chen X. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats. J. Pharm. Pharmacol. 2009;61(4):451–458. doi: 10.1211/jpp/61.04.0006. [DOI] [PubMed] [Google Scholar]
  27. Chattopadhyay R. Hypoglycemic effect of Ocimum sanctum leaf in normal and streptozotocin diabetic rats. Indian J. Exp. Biol. 1993;31:891–893. [PubMed] [Google Scholar]
  28. Chen C.Y., Li H., Yuan Y.N., Dai H.Q., Yang B. Antioxidant activity and components of a traditional Chinese medicine formula consisting of Crataegus pinnatifida and Salvia miltiorrhiza. BMC Complement Altern. Med. 2013;13:99. doi: 10.1186/1472-6882-13-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Chen H., Miao Q., Geng M., Liu J., Hu Y., Tian L., Pan J., Yang Y. Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Sci. World J. 2013;20 doi: 10.1155/2013/269165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Chen I.L., Tsai Y.J., Huang C.M., Tsai T.H. Lymphatic absorption of quercetin and rutin in rat and their pharmacokinetics in systemic plasma. J. Agric. Food Chem. 2010;58(1):546–551. doi: 10.1021/jf9026124. [DOI] [PubMed] [Google Scholar]
  31. Chen W.M., Jin M., Wu W. Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002;22(4):283–285. (Article in Chinese) [PubMed] [Google Scholar]
  32. Chen W.Y., Huang Y.C., Yang M.L., Lee C.Y., Chen C.J., Yeh C.H., Pan P.H., Horng C.T., Kuo W.H., Kuan Y.H. Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation. Int. Immunopharmacol. 2014;22(2):409–413. doi: 10.1016/j.intimp.2014.07.026. [DOI] [PubMed] [Google Scholar]
  33. Chen Y.S., Hu Q.H., Zhang X., Zhu Q., Kong L.D. Beneficial effect of rutin on oxonate-induced hyperuricemia and renal dysfunction in mice. Pharmacology. 2013;92(1–2):75–83. doi: 10.1159/000351703. [DOI] [PubMed] [Google Scholar]
  34. Chiou G.C., Xu X.R. Effects of some natural flavonoids on retinal function recovery after ischemic insult in the rat. J. Ocul. Pharmacol. Ther. 2004;20(2):107–113. doi: 10.1089/108076804773710777. [DOI] [PubMed] [Google Scholar]
  35. Choi J.K., Kim S.H. Rutin suppresses atopic dermatitis and allergic contact dermatitis. Exp. Biol. Med. (Maywood) 2013;238(4):410–417. doi: 10.1177/1535370213477975. [DOI] [PubMed] [Google Scholar]
  36. Choi K.S., Kundu J.K., Chun K.S., Na H.K., Surh Y.J. Rutin inhibits UV-B radiation-induced expression of COX-2 and iNOS in hairless mouse skin: p38 MAP kinase and JNK as potential targets. Arch. Biochem. Biophys. 2014;559:38–45. doi: 10.1016/j.abb.2014.05.016. [DOI] [PubMed] [Google Scholar]
  37. Choquenet B., Couteau C., Paparis E., Coiffard I.J. Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method. J. Nat. Prod. 2008;71:1117–1118. doi: 10.1021/np7007297. [DOI] [PubMed] [Google Scholar]
  38. Choudhury R., Srai S.K., Debnam E., Rice-Evans C.A. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic. Biol. Med. 1999;27(3–4):278–286. doi: 10.1016/s0891-5849(99)00054-4. [DOI] [PubMed] [Google Scholar]
  39. Coombes J., Rowell B., Dodd S., Demirel H., Naito H., Shanely A. Effects of vitamin E deficiency on fatigue and muscle contractile properties. Eur. J. Appl., Physiol. 2002;87:272–277. doi: 10.1007/s00421-002-0631-3. [DOI] [PubMed] [Google Scholar]
  40. Corcostegui R., Labeaga L., Arteche J.K., Orjales A. Protective effect of hidrosmin against cisplatin induced acute nephrotoxicity in rats. Pharm. Pharmacol. Commun. 1998;4(9):465–467. [Google Scholar]
  41. Cristina Marcarini J., Ferreira Tsuboy M.S., Cabral Luiz R., Regina Ribeiro L., Beatriz Hoffmann-Campo C., Ségio Mantovani M. Investigation of cytotoxic, apoptosis-inducing, genotoxic and protective effects of the flavonoid rutin in HTC hepatic cells. Exp. Toxicol. Pathol. 2011;63(5):459–465. doi: 10.1016/j.etp.2010.03.005. [DOI] [PubMed] [Google Scholar]
  42. da Cruz R.C., Agertt V., Boligon A.A., Janovik V., Anraku de Campos M.M., Guillaume D., Athayde M.L. In vitro antimycobacterial activity and HPLC-DAD screening of phenolics from Ficus benjamina L. and Ficus luschnathiana (Miq.) Miq. leaves. Nat. Prod. Res. 2012;26(23):2251–2254. doi: 10.1080/14786419.2011.650637. [DOI] [PubMed] [Google Scholar]
  43. da Silva R.R., de Oliveira T.T., Nagem T.J., Pinto A.S., Albino L.F., de Almeida M.R., de Moraes G.H., Pinto J.G. Hypocholesterolemic effect of naringin and rutin flavonoids. Arch. Latinoam. Nutr. 2001;51(3):258–264. [Article in Portuguese] [PubMed] [Google Scholar]
  44. De Clercq E., Field H.J. Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol. 2006;10:1–11. doi: 10.1038/sj.bjp.0706446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. De Sarmento F.M., Kimura T. Treatment of whooping cough with vitamins C & K combined with rutin, intravenous administration. Pediatr. Prat. 1957;28(1):51–62. [Article in Portuguese] [PubMed] [Google Scholar]
  46. Deb P., Sharma S., Hassan K.M. Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thromlolysis. Pathophysiology. 2010;17:197–218. doi: 10.1016/j.pathophys.2009.12.001. [DOI] [PubMed] [Google Scholar]
  47. Draelos Z.D. Cosmetics and skin care products. A historical perspective. Dermatol. Clin. 2000;18(4):557–559. doi: 10.1016/s0733-8635(05)70206-0. [DOI] [PubMed] [Google Scholar]
  48. Drewa G., Schachtschabel D.O., Pałgan K., Grzanka A., Sujkowska R. The influence of rutin on the weight, metastasis and melanin content of B16 melanotic melanoma in C57BL/6 mice. Neoplasma. 1998;45(4):266–271. [PubMed] [Google Scholar]
  49. Dubey S., Ganeshpurkar A., Bansal D., Dubey N. Experimental studies on bioactive potential of rutin. Chron. Young Sci. 2013;4:153–157. [Google Scholar]
  50. Dubey S., Ganeshpurkar A., Shrivastava A., Bansal D., Dubey N. Rutin exerts antiulcer effect by inhibiting the gastric proton pump. Indian J. Pharmacol. 2013;45(4):415–417. doi: 10.4103/0253-7613.115011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Fernandes A.A., Novelli E.L., Okoshi K., Okoshi M.P., Di Muzio B.P., Guimarães J.F., Fernandes Junior A. Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed. Pharmacother. 2010;64(3):214–219. doi: 10.1016/j.biopha.2009.08.007. [DOI] [PubMed] [Google Scholar]
  52. Fernández S.P., Wasowski C., Loscalzo L.M., Granger R.E., Johnston G.A., Paladini A.C., Marder M. Central nervous system depressant action of flavonoid glycosides. Eur. J. Pharmacol. 2006;539(3):168–176. doi: 10.1016/j.ejphar.2006.04.004. [DOI] [PubMed] [Google Scholar]
  53. Fitts R.H. Cellular mechanisms of muscle fatigue. Physiol. Rev. 1994;74:49–94. doi: 10.1152/physrev.1994.74.1.49. [DOI] [PubMed] [Google Scholar]
  54. Friedman S.L., McQuaid K.R., Grendell J.H. Lang Medical Books/McGraw-Hill; New York: 2002. Current Diagnosis & Treatment in Gastroenterology. [Google Scholar]
  55. Ganesh D., Fuehrer H.P., Starzengrüber P., Swoboda P., Khan W.A., Reismann J.A., Mueller M.S., Chiba P., Noedl H. Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones. Parasitol. Res. 2012;110(6):2289–2295. doi: 10.1007/s00436-011-2763-z. [DOI] [PubMed] [Google Scholar]
  56. Gonçalves C.F., Santos M.C., Ginabreda M.G., Fortunato R.S., Carvalho D.P., Freitas Ferreira A.C. Flavonoid rutin increases thyroid iodide uptake in rats. PLoS One. 2013;8(9):e73908. doi: 10.1371/journal.pone.0073908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Gould L. The medical management of idiopathic chylothorax in a domestic long-haired cat. Can. Vet. J. 2004;45(1):51–54. [PMC free article] [PubMed] [Google Scholar]
  58. Grdina D.J., Murley J.S., Kataoka Y. Radioprotectants: current status and new directions. Oncology. 2002;63(Suppl 2):2–10. doi: 10.1159/000067146. [DOI] [PubMed] [Google Scholar]
  59. Griffiths L.A., Barrow A. Metabolism of flavonoid compounds in germ-free rats. Biochem. J. 1972;130(4):1161–1162. doi: 10.1042/bj1301161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Guardia T., Rotelli A.E., Juarez A.O., Pelzer L.E. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco. 2001;56(9):683–687. doi: 10.1016/s0014-827x(01)01111-9. [DOI] [PubMed] [Google Scholar]
  61. Guerrero L., Castillo J., Quiñones M., Garcia-Vallvé S., Arola L., Pujadas G., Muguerza B. Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS One. 2012;7(11):e49493. doi: 10.1371/journal.pone.0049493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Hammad H.M., Abdalla S.S. Pharmacological effects of selected flavonoids on rat isolated ileum: structure-activity relationship. Gen. Pharmacol. 1997;28(5):767–771. doi: 10.1016/s0306-3623(96)00299-6. [DOI] [PubMed] [Google Scholar]
  63. Han Y. Rutin has therapeutic effect on septic arthritis caused by Candida albicans. Int. Immunopharmacol. 2009;9(2):207–211. doi: 10.1016/j.intimp.2008.11.002. [DOI] [PubMed] [Google Scholar]
  64. Harborne J.B. Nature, distribution and function of plant flavonoids. Prog. Clin. Biol. Res. 1986;213:15–24. [PubMed] [Google Scholar]
  65. Hodsman A.B., Bauer D.C., Dempster D.W., Dian L., Hanley D.A., Harris S.T., Kendler D.L., McClung M.R., Miller P.D., Olszynski W.P., Orwoll E., Yuen C.K. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr. Rev. 2005;26:688–703. doi: 10.1210/er.2004-0006. [DOI] [PubMed] [Google Scholar]
  66. Horcajada M.N., Sanchez C., Membrez Scalfo F., Drion P., Comblain F., Taralla S., Donneau A.F., Offord E.A., Henrotin Y. Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthritis Cartilage. 2014 doi: 10.1016/j.joca.2014.08.016. pii: S1063-4584(14)01249-1257. [DOI] [PubMed] [Google Scholar]
  67. Horcajada-Molteni M.N., Crespy V., Coxam V., Davicco M.J., Rémésy C., Barlet J.P. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res. 2000;15(11):2251–2258. doi: 10.1359/jbmr.2000.15.11.2251. [DOI] [PubMed] [Google Scholar]
  68. Hsieh T.J., Wang J.C., Hu C.Y., Li C.T., Kuo C.M., Hsieh S.L. Effects of rutin from Toona sinensis on the immune and physiological responses of white shrimp (Litopenaeus vannamei) under Vibrio alginolyticus challenge. Fish Shellfish Immunol. 2008;25(5):581–588. doi: 10.1016/j.fsi.2008.07.014. [DOI] [PubMed] [Google Scholar]
  69. Hsu C.Y., Shih H.Y., Chia Y.C., Lee C.H., Ashida H., Lai Y.K., Weng C.F. Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation. Mol. Nutr. Food Res. 2014;58(6):1168–1176. doi: 10.1002/mnfr.201300691. [DOI] [PubMed] [Google Scholar]
  70. Hu Q.H., Wang C., Li J.M., Zhang D.M., Kong L.D. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am. J. Physiol. Renal Physiol. 2009;297(4):F1080–F1091. doi: 10.1152/ajprenal.90767.2008. [DOI] [PubMed] [Google Scholar]
  71. Hu Q.H., Zhang X., Pan Y., Li Y.C., Kong L.D. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem. Pharmacol. 2012;84(1):113–125. doi: 10.1016/j.bcp.2012.03.005. [DOI] [PubMed] [Google Scholar]
  72. Huang Y.C., Horng C.T., Chen S.T., Lee S.S., Yang M.L., Lee C.Y., Kuo W.H., Yeh C.H., Kuan Y.H. Rutin improves endotoxin-induced acute lung injury via inhibition of iNOS and VCAM-1 expression. Environ. Toxicol. 2014;107(3):742–750. doi: 10.1002/tox.22033. [DOI] [PubMed] [Google Scholar]
  73. Hyun H., Park H., Jeong J., Kim J., Kim H., Oh H.I., Hwang H.S., Kim H.H. Effects of watercress containing rutin and rutin alone on the proliferation and osteogenic differentiation of human osteoblast-like MG-63 cells. Korean J. Physiol. Pharmacol. 2014;18(4):347–352. doi: 10.4196/kjpp.2014.18.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Ibrahim A.K., Youssef A.I., Arafa A.S., Ahmed S.A. Anti-H5N1 virus flavonoids from Capparis sinaica Veill. Nat. Prod. Res. 2013;27(22):2149–2153. doi: 10.1080/14786419.2013.790027. [DOI] [PubMed] [Google Scholar]
  75. Isai M., Sakthivel M., Ramesh E., Thomas P.A., Geraldine P. Prevention of selenite-induced cataractogenesis by rutin in Wistar rats. Mol. Vis. 2009;15:2570–2577. [PMC free article] [PubMed] [Google Scholar]
  76. Iwu M.M., Obidoa O., Anazodo M. Biochemical mechanism of the antimalarial activity of Azadirachta indica leaf extract. Pharmacol. Res. Commun. 1986;18(1):81–91. doi: 10.1016/0031-6989(86)90161-x. [DOI] [PubMed] [Google Scholar]
  77. Janbaz K.H., Saeed S.A., Gilani A.H. Protective effect of rutin on paracetamol and CCl4-induced hepatotoxicity in rodents. Fitoterapia. 2002;73:557–563. doi: 10.1016/s0367-326x(02)00217-4. [DOI] [PubMed] [Google Scholar]
  78. Javed H., Khan M.M., Ahmad A., Vaibhav K., Ahmad M.E., Khan A., Ashafaq M., Islam F., Siddiqui M.S., Safhi M.M., Islam F. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience. 2012;17:340–352. doi: 10.1016/j.neuroscience.2012.02.046. [DOI] [PubMed] [Google Scholar]
  79. Johann S., Mendes B.G., Missau F.C., Rezende M.A., Pizzollati M.G. Antifungal activity of five species of Polygala. Braz. J. Microbiol. 2011;42:1065–1075. doi: 10.1590/S1517-838220110003000027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Jung C.H., Lee J.Y., Cho C.H., Kim C.J. Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin. Arch. Pharm. Res. 2007;30(12):1599–1607. doi: 10.1007/BF02977330. [DOI] [PubMed] [Google Scholar]
  81. Kalant H., Grant D.M., Jane M. seventh ed. Elsevier Canada Ltd; 2007. Principles of Medical Pharmacology; pp. 557–559. [Google Scholar]
  82. Kalgaonkar S., Gross H.B., Yokoyama W., Keen C.L. Effects of a flavonol-rich diet on select cardiovascular parameters in a Golden Syrian hamster model. J. Med. Food. 2010;13(1):108–115. doi: 10.1089/jmf.2008.0295. [DOI] [PubMed] [Google Scholar]
  83. Kamalakkannan N., Prince P.S. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin. Pharmacol. Toxicol. 2006;98(1):97–103. doi: 10.1111/j.1742-7843.2006.pto_241.x. [DOI] [PubMed] [Google Scholar]
  84. Kamalakkannan N., Stanely Mainzen Prince P. The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney. J. Pharm. Pharmacol. 2006;58(8):1091–1098. doi: 10.1211/jpp.58.8.0010. [DOI] [PubMed] [Google Scholar]
  85. Kamel K.M., Abd El-Raouf O.M., Metwally S.A., Abd El-Latif H.A., El-sayed M.E. Hesperidin and rutin, antioxidant citrus flavonoids, attenuate cisplatin-induced nephrotoxicity in rats. J. Biochem. Mol. Toxicol. 2014;28(7):312–319. doi: 10.1002/jbt.21567. [DOI] [PubMed] [Google Scholar]
  86. Kanashiro A., Andrade D.C., Kabeya L.M., Turato W.M., Faccioli L.H., Uyemura S.A., Lucisano-Valim Y.M. Modulatory effects of rutin on biochemical and hematological parameters in hypercholesterolemic Golden Syrian hamsters. An. Acad. Bras. Cienc. 2009;81(1):67–72. doi: 10.1590/s0001-37652009000100009. [DOI] [PubMed] [Google Scholar]
  87. Kappel V.D., Zanatta L., Postal B.G., Silva F.R. Rutin potentiates calcium uptake via voltage-dependent calcium channel associated with stimulation of glucose uptake in skeletal muscle. Arch Biochem. Biophys. 2013;532(2):55–60. doi: 10.1016/j.abb.2013.01.008. [DOI] [PubMed] [Google Scholar]
  88. Karami M., Karimian Nokabadi F., Ebrahimzadeh M.A., Naghshvar F. Nephroprotective effects of Feijoa Sellowiana leaves extract on renal injury induced by acute dose of ecstasy (MDMA) in mice. Iran J. Basic Med. Sci. 2014;17(1):69–72. [PMC free article] [PubMed] [Google Scholar]
  89. Khan M.M., Ahmad A., Ishrat T., Khuwaja G., Srivastawa P., Khan M.B., Raza S.S., Javed H., Vaibhav K., Khan A., Islam F. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res. 2009;1292:123–135. doi: 10.1016/j.brainres.2009.07.026. [DOI] [PubMed] [Google Scholar]
  90. Khan R.A., Khan M.R., Sahreen S. CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement. Altern. Med. 2012;12:178. doi: 10.1186/1472-6882-12-178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Khan R.A., Khan M.R., Sahreen S. Protective effects of rutin against potassium bromate induced nephrotoxicity in rats. BMC Complement. Altern. Med. 2012;12:204. doi: 10.1186/1472-6882-12-204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Kim D.W., Hwang I.K., Lim S.S., Yoo K.Y., Li H., Kim Y.S., Kwon D.Y., Moon W.K., Kim D.W., Won M.H. Germinated Buckwheat extract decreases blood pressure and nitrotyrosine immunoreactivity in aortic endothelial cells in spontaneously hypertensive rats. Phytother. Res. 2009;23(7):993–998. doi: 10.1002/ptr.2739. [DOI] [PubMed] [Google Scholar]
  93. Kopko S.H. The use of rutin in a cat with idiopathic chylothorax. Can. Vet. J. 2005;46(8):729–731. [PMC free article] [PubMed] [Google Scholar]
  94. Korkmaz A., Kolankaya D. Inhibiting inducible nitric oxide synthase with rutin reduces renal ischemia/reperfusion injury. Can. J. Surg. 2013;56(1):6–14. doi: 10.1503/cjs.004811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Korkmaz A., Kolankaya D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J. Surg. Res. 2010;164(2):309–315. doi: 10.1016/j.jss.2009.03.022. [DOI] [PubMed] [Google Scholar]
  96. Kourounakis P., Rekka E. Effect of benzopyrone derivatives on drug activity and metabolism. Eur. J. Drug Metab. Pharmacokinet. 1986;11(4):269–273. doi: 10.1007/BF03189111. [DOI] [PubMed] [Google Scholar]
  97. Kreft S., Knapp M., Kreft I. Extraction of rutin from buckwheat (Fagopyrum esculentum Moench) seeds and determination by capillary electrophoresis. J. Agric. Food Chem. 1997;47(11):4649–4652. doi: 10.1021/jf990186p. [DOI] [PubMed] [Google Scholar]
  98. Krishna K.M., Annapurna A., Gopal G.S., Chalam C.R., Madan K., Kumar V.K., Prakash G.J. Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats. Can. J. Physiol. Pharmacol. 2005;83(4):343–355. doi: 10.1139/y05-009. [DOI] [PubMed] [Google Scholar]
  99. Kumar K.K., Priyanka L., Gnananath K., Babu P.R., Sujatha S. Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats. Eur. J. Drug Metab. Pharmacokinet. 2015;40(3):267–276. doi: 10.1007/s13318-014-0203-z. [DOI] [PubMed] [Google Scholar]
  100. Kyung T.W., Lee J.E., Shin H.H., Choi H.S. Rutin inhibits osteoclast formation by decreasing reactive oxygen species and TNF-alpha by inhibiting activation of NF-kappaB. Exp. Mol. Med. 2008;40(1):52–58. doi: 10.3858/emm.2008.40.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. La Casa C., Villegas I., Alarcón de la Lastra C., Motilva V., Martín Calero M.J. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J. Ethnopharmacol. 2000;71(1–2):45–53. doi: 10.1016/s0378-8741(99)00174-9. [DOI] [PubMed] [Google Scholar]
  102. Lau R.Y., Guo X. A review on current osteoporosis research: with special focus on disuse bone loss. J. Osteoporos. 2011;5 doi: 10.4061/2011/293808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Li C., Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 2002;282:C227–C241. doi: 10.1152/ajpcell.00112.2001. [DOI] [PubMed] [Google Scholar]
  104. Li M., Jiang Y., Jing W., Sun B., Miao C., Ren L. Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat. Can. J. Physiol. Pharmacol. 2013;91(11):951–959. doi: 10.1139/cjpp-2012-0432. [DOI] [PubMed] [Google Scholar]
  105. Lin J.P., Yang J.S., Lin J.J., Lai K.C., Lu H.F., Ma C.Y., Sai-Chuen Wu R., Wu K.C., Chueh F.S., Gibson Wood W., Chung J.G. Rutin inhibits human leukemia tumor growth in a murine xenograft model in vivo. Environ. Toxicol. 2012;27(8):480–484. doi: 10.1002/tox.20662. [DOI] [PubMed] [Google Scholar]
  106. Lin J.P., Yang J.S., Lu C.C., Chiang J.H., Wu C.L., Lin J.J., Lin H.L., Yang M.D., Liu K.C., Chiu T.H., Chung J.G. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk. Res. 2009;33(6):823–828. doi: 10.1016/j.leukres.2008.09.032. [DOI] [PubMed] [Google Scholar]
  107. Lindahl M., Tagesson C. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 1997;21(3):347–356. doi: 10.1023/a:1027306118026. [DOI] [PubMed] [Google Scholar]
  108. Lloyd-Jones D., Adams H.P., Carnethon M., De Simone G., Ferguson T.B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., Mcdermott M., Meigs J., Mozaffarian D., Nichol G., O’donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y. Heart disease and stroke statistics 2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2009;11:e71–e87. doi: 10.1161/CIRCULATIONAHA.108.191261. [DOI] [PubMed] [Google Scholar]
  109. Machado D.G., Bettio L.E., Cunha M.P., Santos A.R., Pizzolatti M.G., Brighente I.M., Rodrigues A.L. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur. J. Pharmacol. 2008;587(1–3):163–168. doi: 10.1016/j.ejphar.2008.03.021. [DOI] [PubMed] [Google Scholar]
  110. Markert C., Markert C. Neoplasia: a disease of differentiation. Cancer Res. 1968;28:1908–1914. [PubMed] [Google Scholar]
  111. Martínez Conesa C., Vicente Ortega V., Yáñez Gascón M.J., Alcaraz Baños M., Canteras Jordana M., Benavente-García O., Castillo J. Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. J. Agric. Food Chem. 2005;53(17):6791–6797. doi: 10.1021/jf058050g. [DOI] [PubMed] [Google Scholar]
  112. Mellou F., Loutrari H., Stamatis H., Roussos C., Kolisis F.N. Enzymatic esterification of flavonoids with unsaturated fatty acids: effect of the novel esters on vascular endothelial growth factor release from K562 cells. Process Biochem. 2006;41:2029–3204. [Google Scholar]
  113. Mendes-Junior Ld., Monteiro M.M., Carvalho Ados S., Queiroz T.M., Braga de A. Oral supplementation with the rutin improves cardiovagal baroreflex sensitivity and vascular reactivity in hypertensive rats. Appl. Physiol. Nutr. Metab. 2013;38(11):1099–1106. doi: 10.1139/apnm-2013-0091. [DOI] [PubMed] [Google Scholar]
  114. Moretti E., Mazzi L., Terzuoli G., Bonechi C., Iacoponi F., Martini S., Rossi C., Collodel G. Effect of quercetin, rutin, naringenin and epicatechin on lipid peroxidation induced in human sperm. Reprod. Toxicol. 2012;34(4):651–657. doi: 10.1016/j.reprotox.2012.10.002. [DOI] [PubMed] [Google Scholar]
  115. Morino K., Matsukara N., Kawachi T., Ohgaki H., Sugimura T., Hirono I. Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration. Carcinogenesis. 1982;3(1):93–97. doi: 10.1093/carcin/3.1.93. [DOI] [PubMed] [Google Scholar]
  116. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer. 2002;98(5):761–769. doi: 10.1002/ijc.10202. [DOI] [PubMed] [Google Scholar]
  117. Muthenna P., Akileshwari C., Saraswat M., Bhanuprakash Reddy G. Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br. J. Nutr. 2010;107(7):941–949. doi: 10.1017/S0007114511004077. [DOI] [PubMed] [Google Scholar]
  118. Nassiri-Asl M., Mortazavi S.R., Samiee-Rad F., Zangivand A.A., Safdari F., Saroukhani S., Abbasi E. The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats. Epilepsy Behav. 2010;18:50–53. doi: 10.1016/j.yebeh.2010.03.005. [DOI] [PubMed] [Google Scholar]
  119. Nebbioso M., Rusciano D., Pucci B., Zicari A.M., Grenga R., Pescocolido N. Treatment of glaucomatous patients by means of food supplement to reduce the ocular discomfort: a double blind randomized trial. Eur. Rev. Med. Pharmacol. Sci. 2013;17(8):1117–1122. [PubMed] [Google Scholar]
  120. Nieoczym D., Socała K., Raszewski G., Wlaź P. Effect of quercetin and rutin in some acute seizure models in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014;54:50–58. doi: 10.1016/j.pnpbp.2014.05.007. [DOI] [PubMed] [Google Scholar]
  121. Nones J., Costa A.P., Leal R.B., Gomes F.C., Trentin A.G. The flavonoids hesperidin and rutin promote neural crest cell survival. Cell Tissue Res. 2012;350(2):305–315. doi: 10.1007/s00441-012-1472-y. [DOI] [PubMed] [Google Scholar]
  122. Oates P.J., Hakkinen J.P. Studies on the mechanism of ethanol-induced gastric damage in rat. Gastroenterology. 1988;94:10–21. doi: 10.1016/0016-5085(88)90604-x. [DOI] [PubMed] [Google Scholar]
  123. O’Connell M., Rushworth S. Curcumin: potential for hepatic fibrosis therapy? Br. J. Pharmacol. 2008;153(3):403–405. doi: 10.1038/sj.bjp.0707580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Odetti P.R., Borgoglio A., De Pascale A., Rolandi R., Adezati L. Prevention of diabetes-increased aging effect on rat collagen-linked fluorescence by aminoguanidine and rutin. Diabetes. 1990;39(7):796–801. doi: 10.2337/diab.39.7.796. [DOI] [PubMed] [Google Scholar]
  125. Ogeturk M., Kus I., Colakoglu N., Zararsiz I., Ilhan N., Sarsilmaz M. Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J. Ethnopharmacol. 2005;97:273–280. doi: 10.1016/j.jep.2004.11.019. [DOI] [PubMed] [Google Scholar]
  126. Ortolani O., Caggiano M., Mannelli R., Gogliettino A., Tufano R. Protection from ischemia-reperfusion damage in patients with stroke: the role of rutin and GSH. Transplant. Proc. 1995;27(5):2877–2878. [PubMed] [Google Scholar]
  127. Ortolani O., Conti A., De Gaudio A.R., Masoni M., Novelli G. Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome. Shock. 2000;13(1):14–18. doi: 10.1097/00024382-200013010-00003. [DOI] [PubMed] [Google Scholar]
  128. Ostrakhovitch E.A., Afanas’ev I.B. Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators. Biochem. Pharmacol. 2001;62(6):743–746. doi: 10.1016/s0006-2952(01)00707-9. [DOI] [PubMed] [Google Scholar]
  129. Pashikanti S., de Alba D.R., Boissonneault G.A., Cervantes-Laurean D. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. Free Radic. Biol. Med. 2010;48(5):656–663. doi: 10.1016/j.freeradbiomed.2009.11.019. [DOI] [PubMed] [Google Scholar]
  130. Patil S.L., Mallaiah S.H., Patil R.K. Antioxidative and radioprotective potential of rutin and quercetin in Swiss albino mice exposed to gamma radiation. J. Med. Phys. 2013;38(2):87–92. doi: 10.4103/0971-6203.111321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Patil S.L., Somashekarappa H., Rajashekhar K. Radiomodulatory role of rutin and quercetin in swiss albino mice exposed to the whole body gamma radiation. Indian J. Nucl. Med. 2012;27(4):237–242. doi: 10.4103/0972-3919.115394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Pihan G., Regillo C., Szabo S. Free radicals and lipid peroxidation in ethanol- and aspirin-induced gastric mucosal injury. Dig. Dis. Sci. 1987;32:1395–1401. doi: 10.1007/BF01296666. [DOI] [PubMed] [Google Scholar]
  133. Pimentel R.B., da Costa C.A., Albuquerque P.M., Junior S.D. Antimicrobial activity and rutin identification of honey produced by the stingless bee Melipona compressipes manaosensis and commercial honey. BMC Complement. Altern. Med. 2013;13:151. doi: 10.1186/1472-6882-13-151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Pozin V.M., Skuratovskaia S.G., Pocheptsova G.A. Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia. Fiziol. Zh. 1996;42(1–2):10–16. [PubMed] [Google Scholar]
  135. Pu F., Mishima K., Irie K., Motohashi K., Tanaka Y., Orito K., Egawa T., Kitamura Y., Egashira N., Iwasaki K., Fujiwara M. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J. Pharmacol. Sci. 2007;104:329–334. doi: 10.1254/jphs.fp0070247. [DOI] [PubMed] [Google Scholar]
  136. Ratty A.K., Das N.P. Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem. Med. Metab. Biol. 1988;39(1):69–79. doi: 10.1016/0885-4505(88)90060-6. [DOI] [PubMed] [Google Scholar]
  137. Richetti S.K., Blank M., Capiotti K.M., Piato A.L., Bogo M.R., Vianna M.R., Bonan C.D. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav. Brain Res. 2011;217:10–15. doi: 10.1016/j.bbr.2010.09.027. [DOI] [PubMed] [Google Scholar]
  138. Roseghini R., Rocha D.S., Clarêncio J., Costa S.L., Costa M.F., Tardy M., Nascimento R., Schaer R., Velozo E., Meyer R., Freire S. Flavonoid rutin alters the viability and function of mitogen-stimulated splenocytes and thymocytes compared with non stimulated cells. Immunopharmacol. Immunotoxicol. 2007;29(2):271–285. doi: 10.1080/08923970701512940. [DOI] [PubMed] [Google Scholar]
  139. Roux S. New treatment targets in osteoporosis. Joint Bone Spine. 2010;77:222–228. doi: 10.1016/j.jbspin.2010.02.004. [DOI] [PubMed] [Google Scholar]
  140. Rylski M., Duriasz-Rowińska H., Rewerski W. The analgesic action of some flavonoids in the hot plate test. Acta Physiol. Pol. 1979;30(3):385–388. doi: 10.103/00006450-01000-0000. [DOI] [PubMed] [Google Scholar]
  141. Scambia G., Ranelletti F.O., Benedetti Panici P., Bonanno G., De Vincenzo R., Piantelli M., Mancuso S. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer Drugs. 1990;1(1):45–48. doi: 10.1097/00001813-199010000-00008. [DOI] [PubMed] [Google Scholar]
  142. Schuller S., Le Garrérès A., Remy I., Peeters D. Idiopathic chylothorax and lymphedema in 2 whippet littermates. Can. Vet. J. 2011;52(11):1243–1245. [PMC free article] [PubMed] [Google Scholar]
  143. Schwedhelm E., Maas R., Troost R., Böger R.H. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin. Pharmacokinet. 2003;42:437–459. doi: 10.2165/00003088-200342050-00003. [DOI] [PubMed] [Google Scholar]
  144. Schwingel T.E., Klein C.P., Nicoletti N.F., Dora C.L., Hadrich G., Bica C.G., Lopes T.G., da Silva V.D., Morrone F.B. Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice. Naunyn. Schmiedebergs Arch. Pharmacol. 2014;387(9):837–848. doi: 10.1007/s00210-014-0994-0. [DOI] [PubMed] [Google Scholar]
  145. Selvaraj G., Kaliamurthi S., Thirungnasambandam R., Vivekanandan L., Balasubramanian T. Anti-nociceptive effect in mice of thillai flavonoid rutin. Biomed. Environ. Sci. 2014;27(4):295–299. doi: 10.3967/bes2014.052. [DOI] [PubMed] [Google Scholar]
  146. Shen H. Illustrated pharmacology memory cards: pharmnemonics. Minireview. 2008:5. [Google Scholar]
  147. Silveira P., Vashist U., Cabral A., Amaral K.B., Soares G.L., Dagosto M. Effect of rutin and chloroquine on White Leghorn chickens infected with Plasmodium (Bennettinia) juxtanucleare. Trop. Anim. Health Prod. 2009;41(7):1319–1323. doi: 10.1007/s11250-009-9317-8. [DOI] [PubMed] [Google Scholar]
  148. Sonkar N., Ganeshpurkar A., Yadav P., Dubey S., Bansal D., Dubey N. An experimental evaluation of nephroprotective potential of Butea monosperma extract in albino rats. Indian J. Pharmacol. 2014;46(1):109–112. doi: 10.4103/0253-7613.125190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Srinivasan K., Kaul C.L., Ramarao P. Partial protective effect of rutin on multiple low dose streptozotocin-induced diabetes in mice. Indian J. Pharmacol. 2005;37:327–328. [Google Scholar]
  150. Stanley Mainzen Prince P., Kamalakkannan N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 2006;20(2):96–102. doi: 10.1002/jbt.20117. [DOI] [PubMed] [Google Scholar]
  151. Stojković D., Petrović J., Soković M., Glamočlija J., Kukić-Marković J., Petrović S. In situ antioxidant and antimicrobial activities of naturally occurring caffeic acid, p-coumaric acid and rutin, using food systems. J. Sci. Food Agric. 2013;93(13):3205–3208. doi: 10.1002/jsfa.6156. [DOI] [PubMed] [Google Scholar]
  152. Su K.Y., Yu C.Y., Chen Y.W., Huang Y.T., Chen C.T., Wu H.F., Chen Y.L. Rutin, a flavonoid and principal component of Saussurea involucrata, attenuates physical fatigue in a forced swimming mouse model. Int. J. Med. Sci. 2014;11(5):528–537. doi: 10.7150/ijms.8220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Szabo S., Goldberg I. Experimental pathogenesis: drugs and chemical lesions in the gastric mucosa. Scand. J. Gastroenterol. 1990;(Suppl 174):1–8. doi: 10.3109/00365529009091924. [DOI] [PubMed] [Google Scholar]
  154. Szelenyi I., Brune K. Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig. Dis. Sci. 1988;33:865–871. doi: 10.1007/BF01550977. [DOI] [PubMed] [Google Scholar]
  155. Tao J., Hu Q., Yang J., Li R., Li X., Lu C., Chen C., Wang L., Shattock R., Ben K. In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidate. Antiviral Res. 2007;75(3):227–233. doi: 10.1016/j.antiviral.2007.03.008. [DOI] [PubMed] [Google Scholar]
  156. Tongjaroenbuangam W., Ruksee N., Chantiratikul P., Pakdeenarong N., Kongbuntad W., Govitrapong P. Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem. Int. 2011;59:677–685. doi: 10.1016/j.neuint.2011.06.014. [DOI] [PubMed] [Google Scholar]
  157. Tran N.Q., Joung Y.K., Lih E., Park K.D. In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules. 2011;12(8):2872–2880. doi: 10.1021/bm200326g. [DOI] [PubMed] [Google Scholar]
  158. Trumbeckaite S., Bernatoniene J., Majiene D., Jakstas V., Savickas A., Toleikis A. The effect of flavonoids on rat heart mitochondrial function. Biomed. Pharmacother. 2006;60:245–248. doi: 10.1016/j.biopha.2006.04.003. [DOI] [PubMed] [Google Scholar]
  159. Ugusman A., Zakaria Z., Chua K.H., Nordin N.A., Abdullah Mahdy Z. Role of rutin on nitric oxide synthesis in human umbilical vein endothelial cells. Sci. World J. 2014 doi: 10.1155/2014/169370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Vetrugno M., Uva M.G., Russo V., Iester M., Ciancaglini M., Brusini P., Centofanti M., Rossetti L.M. Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapy. J. Ocul. Pharmacol. Ther. 2012;28(5):536–541. doi: 10.1089/jop.2012.0021. [DOI] [PubMed] [Google Scholar]
  161. Wacker A., Eilmes H.G. Antiviral activity of plant components. 1st communication: Flavonoids (author’s transl) Arzneimittelforschung. 1978;28(3):347–350. [Article in German] [PubMed] [Google Scholar]
  162. Wang, S., Nagrath, D., 2010. Liver tissue engineering. In: Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends, 14, 389.
  163. Wang S.W., Wang Y.J., Su Y.J., Zhou W.W., Yang S.G., Zhang R., Zhao M., Li Y.N., Zhang Z.P., Zhan D.W., Liu R.T. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology. 2012;33(3):482–490. doi: 10.1016/j.neuro.2012.03.003. [DOI] [PubMed] [Google Scholar]
  164. Weiss J.F., Landauer M.R. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology. 2003;189:1–20. doi: 10.1016/s0300-483x(03)00149-5. [DOI] [PubMed] [Google Scholar]
  165. Xie Y., Yang W., Chen X., Xiao J. Inhibition of flavonoids on acetylcholine esterase: binding and structure-activity relationship. Food Funct. 2014;5(10):2582–2589. doi: 10.1039/c4fo00287c. [DOI] [PubMed] [Google Scholar]
  166. Xu Y.C., Leung S.W., Yeung D.K., Hu L.H., Chen G.H., Che C.M., Man R.Y. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery. Phytochemistry. 2007;68(8):1179–1188. doi: 10.1016/j.phytochem.2007.02.013. [DOI] [PubMed] [Google Scholar]
  167. Yang Y.J., Yang Z.L., Wang D.C., Xiao X.C., Li P. Comparative study on effects of rutin and quercetin on metabolism in osteoblast cells. Zhong Yao Cai. 2006;29(5):467–470. [PubMed] [Google Scholar]
  168. Yeh C.H., Yang J.J., Yang M.L., Li Y.C., Kuan Y.H. Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway. Free Radic. Biol. Med. 2014;69:249–257. doi: 10.1016/j.freeradbiomed.2014.01.028. [DOI] [PubMed] [Google Scholar]
  169. You L., Zhao M., Regenstein J., Ren J. In vitro antioxidant activity and in vivo anti-fatigue effect of loach (Misgurnus anguillicaudatus) peptides prepared by papain digestion. Food Chem. 2011;124:188–194. doi: 10.1021/jf2016368. [DOI] [PubMed] [Google Scholar]
  170. Yu D.S.F., Lee D.T.F., Man N.W. Fatigue among older people: a review of the research literature. Int. J. Nursing Stud. 2010;47:216–228. doi: 10.1016/j.ijnurstu.2009.05.009. [DOI] [PubMed] [Google Scholar]
  171. Zhang J.G., Lindup W.E. Role of mitochondria in Cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 1993;45:2215–2222. [PubMed] [Google Scholar]

Articles from Saudi Pharmaceutical Journal : SPJ are provided here courtesy of Elsevier

RESOURCES